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Gene expression profiles in normal human tissues <p>A systematic survey of gene expression in 115 human tissue samples using cDNA microarrays provides a dataset that can be used as a  baseline for comparison with expression in diseased tissue.</p>
Abstract
Background: Numerous studies have used DNA microarrays to survey gene expression in cancer
and other disease states. Comparatively little is known about the genes expressed across the gamut
of normal human tissues. Systematic studies of global gene-expression patterns, by linking variation
in the expression of specific genes to phenotypic variation in the cells or tissues in which they are
expressed, provide clues to the molecular organization of diverse cells and to the potential roles
of the genes.
Results: Here we describe a systematic survey of gene expression in 115 human tissue samples
representing 35 different tissue types, using cDNA microarrays representing approximately 26,000
different human genes. Unsupervised hierarchical cluster analysis of the gene-expression patterns
in these tissues identified clusters of genes with related biological functions and grouped the tissue
specimens in a pattern that reflected their anatomic locations, cellular compositions or physiologic
functions. In unsupervised and supervised analyses, tissue-specific patterns of gene expression were
readily discernable. By comparative hybridization to normal genomic DNA, we were also able to
estimate transcript abundances for expressed genes.
Conclusions: Our dataset provides a baseline for comparison to diseased tissues, and will aid in
the identification of tissue-specific functions. In addition, our analysis identifies potential molecular
markers for detection of injury to specific organs and tissues, and provides a foundation for
selection of potential targets for selective anticancer therapy.
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Background
DNA microarrays [1,2] have been used to profile gene expres-
sion in cancer and other diseases. In cancer, for example,
microarray profiling has been applied to classify tumors
according to their sites of origin [3-5], to discover previously
unrecognized subtypes of cancer [6-11], to predict clinical
outcome [12-14] and to suggest targets for therapy [15,16].
However, the identification of improved markers for diagno-
sis and molecular targets for therapy will depend on knowl-
edge not only of the genes expressed in the diseased tissues of
interest, but also on detailed information about the expres-
sion of the corresponding genes across the gamut of normal
human tissues.
At present there is relatively little data on gene expression
across the diversity of normal human tissues [17-20]. Here we
report a DNA microarray-based survey of gene expression in
a diverse collection of normal human tissues and also present
an empirical method for estimating transcript abundance
from DNA microarray data.
Results
Hierarchical clustering of gene expression in normal 
tissues
To survey gene expression across normal human tissues, we
analyzed 115 normal tissue specimens representing 35 differ-
ent human tissue types, using cDNA microarray representing
26,260 different genes (see Materials and methods). To
explore the relationship among samples and underlying fea-
tures of gene expression, we applied an unsupervised two-
way (that is, genes against samples) hierarchical clustering
method using the 5,592 cDNAs (representing 3,960 different
UniGene clusters [21]) whose expression varied most across
samples (Figure 1a; also see Additional data file 2). Overall,
tissue samples clustered in large part according to their ana-
tomic locations, cellular compositions or physiologic func-
tions (Figure 1b). For example, lymphoid tissues (lymph
node, tonsil, thymus, buffy coat and spleen) clustered
together, as did gastrointestinal tissues (stomach, gall blad-
der, liver, pancreas, small bowel and colon), muscular tissues
(heart and skeletal muscle), secretory tissues (parathyroid,
thyroid, prostate, seminal vesicle and salivary gland), and
female genitourinary tissues (ovary, fallopian tube, uterus,
cervix and bladder). Brain and testis were also found to clus-
ter together, largely because genes encoding ribosomal pro-
teins and lymphoid-specific genes were expressed at
particularly low levels in both tissues, the latter possibly
reflecting immunological privilege [22].
The two-way unsupervised analysis also identified clusters of
coexpressed genes (annotated in Figure 1), which represented
both tissue-specific structures and systems (discussed further
below) and coordinately regulated cellular processes. For
example, on the basis of the shared characteristics of well
annotated genes in the clusters, we identified clusters repre-
senting cell proliferation [23], mitochondrial ATP produc-
tion, mRNA processing, protein translation and endoplasmic
reticulum-associated protein modification and secretion.
Interestingly, proliferation, mitochondrial ATP production
and protein translation were each represented by two distinct
clusters of genes, suggesting that subsets of these functions
might be differentially regulated among different tissues. One
gene cluster corresponded to sequences on the mitochondrial
chromosome [24]; we interpret this feature to reflect the rel-
ative abundance of mitochondria in each tissue sample.
Identifying tissue-specific gene expression
While tissue-specific gene expression features were apparent
in the hierarchical cluster, in order to identify tissue-specific
genes more systematically we performed supervised analyses
using the significance analysis of microarrays (SAM) method
([25], see Materials and methods). Tissue-specific genes were
identified for all tissues analyzed, and included named genes
with known tissue-specific functions, as well as named genes
and anonymous expressed sequence tags (ESTs) that had not
been previously characterized as having tissue-specific func-
tions. For example, while the set of liver-specific genes (Fig-
ure 2) included, as expected, genes encoding blood-clotting
factors (for example, F2, F7), complement components (C1R,
C2), lipid (APOB, APOE) and metal transport proteins (TF,
CP), and proteins for detoxification (CYP2D6,  CYP3A7),
amino acid metabolism (PAH,  HAL) and carbohydrate
metabolism (G6PT1, GYS2), other intriguing genes, for exam-
ple, WRNIP1 (Werner helicase interacting protein 1), BIRC5
(survivin),  ANGPTL3  (angiopoietin-like 3), and CNTNAP1
(contactin associated protein 1), were also identified as selec-
tively expressed in liver. The new connections these results
might make between our knowledge of the gene and its prod-
uct on the one hand, and our knowledge of the physiological
functions, cellular characteristics and pathologies of a specific
organ, on the other, are a step towards better understanding
of both the genes and the organs. Interestingly, we also iden-
tified a smaller number of genes displaying selectively
decreased expression in some organs, for example, splicing
factor SF3B1 in the liver (Figure 2b): we speculate that the
decreased expression of such genes may have a role in regu-
lating cellular/tissue differentiation. Tissue-specific genes
characteristically expressed in each of the tissues we exam-
ined are viewable in Additional data file 6 (see also Additional
data file 3).
Recent efforts by the Gene Ontology (GO) Consortium have
r e s u l t e d  i n  t h e  s y s t e m a t i c  a n n o t a t i o n  o f  g e n e s ,  a s c r i b i n g
genes to specific biological processes, cellular components
and molecular functions [26]. This annotation system, while
rudimentary, facilitates the systematic exploration of the
expression of genes reflecting specific biological processes,
cellular components and molecular functions in these normal
tissues. For example, the gene sets encoding tyrosine kinase,
G-protein-coupled receptor and transcription factor func-
tions, as well as components of the extracellular matrix andhttp://genomebiology.com/2005/6/3/R22 Genome Biology 2005,     Volume 6, Issue 3, Article R22       Shyamsundar et al. R22.3
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Hierarchical cluster analysis of normal tissue specimens Figure 1
Hierarchical cluster analysis of normal tissue specimens. (a) Thumbnail overview of the two-way hierarchical cluster of 115 normal tissue specimens 
(columns) and 5,592 variably-expressed genes (rows). Mean-centered gene expression ratios are depicted by a log2 pseudocolor scale (ratio fold-change 
indicated); gray denotes poorly-measured data. Selected gene-expression clusters are annotated. The dataset represented here is available as Additional 
data file 2. (b) Enlarged view of the sample dendrogram. Terminal branches for samples are color-coded by tissue type.
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the process of programmed cell death, each demonstrate tis-
sue-specific patterns of expression (Figure 3; see also Addi-
tional data files 4 and 7).
Estimating transcript abundance
DNA microarray experiments are often performed as com-
parative two-color hybridizations, permitting precise quanti-
fication of the ratio of each gene's expression between two
samples. In the experiments reported here, each tissue sam-
ple was compared by hybridization to the same 'common ref-
erence' mRNA (see Materials and methods), a standard
experimental design permitting the comparison of expression
across all samples [27]. Therefore, the primary measure-
ments give us a precise picture of the variation in relative lev-
els of each gene's expression among the samples. While this
information is sufficient for many purposes, a quantitative
comparison of the expression levels of transcripts of different
genes is also of interest, for example in selecting especially
highly expressed genes for potential diagnostic markers or
therapeutic targets. Single-channel fluorescence intensities
can provide a crude estimate of the relative transcript abun-
dance of different genes, but do not control for the variable
quantities of spotted DNA.
To estimate transcript levels for our dataset, we used micro-
array hybridization to compare the common reference mRNA
against normal female genomic DNA. We reasoned that, for
each gene on the microarray, the ratio of mRNA to genomic
DNA should reflect the relative level of transcript in the com-
mon reference compared to normal genomic DNA (for which
each gene is present in two copies per cell). For each tissue
sample in our study, the ratio of expression for each gene in
that sample versus common reference mRNA, multiplied by
the ratio for that gene in common reference mRNA versus
Liver-specific gene expression Figure 2
Liver-specific gene expression. (a) Thumbnail overview of a hierarchical cluster of 115 normal tissue specimens and 353 variably expressed genes 
identified using the SAM method (see Materials and methods) as selectively expressed in liver (false discovery rate = 0.12%). Genes are hierarchically 
clustered, while samples are grouped by tissue type and ordered according to anatomical location/function. Mean-centered gene-expression ratios are 
depicted by a log2 pseudocolor scale (indicated); samples are color-coded by tissue type. (b-d) Selected gene-expression clusters (locations indicated by 
vertical colored bars). Because of space limitations, only named genes (and not expressed sequence tags (ESTs)) are indicated. Tissue-specific genes 
identified for other tissues are available as Additional data files 3 and 6.
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normal genomic DNA, would then approximate transcript
abundance. To test our approach, we compared our estimates
of transcript levels for a single prostate specimen, calculated
either indirectly using the common reference mRNA versus
genomic DNA ratios, or calculated through a direct hybridiza-
tion comparison of prostate sample mRNA versus normal
female genomic DNA. Our results show high concordance for
the prostate sample (Figure 4a); comparable results were
obtained in a similar analysis using liver, breast, heart and
kidney specimens (data not shown).
The utility of this approach is illustrated for the cluster of
prostate-specific genes (derived from the hierarchical cluster
in Figure 1), and is evident on comparing results depicting the
relative level of each gene's expression in different samples
(Figure 4b), and the relative levels of transcripts for different
genes (Figure 4c). While all genes within the prostate-specific
cluster were expressed at relatively increased levels in pros-
tate compared with other tissues, estimates of transcript
abundance indicated that only a subset of these genes was
highly expressed in the prostate (Figure 4c). For example,
RDH11 was highly expressed in prostate and was expressed at
lower levels in other tissues, while STEAP2 was expressed at
low levels in prostate and displayed very little or no expres-
sion in other tissues. For each of the tissue types, transcripts
identified as both highly abundant and tissue specific are
Brain-selective expression of functionally annotated gene sets Figure 3
Brain-selective expression of functionally annotated gene sets. Hierarchical cluster of 115 normal tissue specimens and annotated gene sets representing 
the following examples of (a-c) specific molecular functions (a) tyrosine kinase, (b) G-protein-coupled receptor, (c) transcription factor, (d) cellular 
components (extracellular matrix) or (e) biological processes (programmed cell death). Samples are ordered as in Figure 2. Genes are ordered by 
hierarchical clustering. For gene selection, we considered genes that were well measured in at least 50% of samples; no ratio-fold cutoff was applied. Only 
features representing brain-specific expression are shown here; the complete clusters are available as Additional data files 4 and 7.
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Estimating relative transcript abundance Figure 4
Estimating relative transcript abundance. (a) Comparison of transcript levels estimated either directly by hybridization of prostate sample mRNA versus 
normal female genomic DNA, or indirectly by multiplying the ratio of prostate sample mRNA vs common reference mRNA by the ratio of common 
reference mRNA vs normal female genomic DNA. The correlation value (R) is indicated. (b) Prostate-specific gene-expression cluster, extracted from the 
hierarchical cluster shown in Figure 1a, is displayed as mean-centered relative gene expression (ratio-fold change scale indicated). (c) The same gene-
expression feature as in (b), is now displayed as transcript abundance (relative to the average transcript level for all expressed genes), calculated indirectly 
using the common reference mRNA versus normal female genomic DNA hybridization data.
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displayed in Additional data files 5 and 8 (for the transcript
levels of all variably expressed genes, see Additional data file
2).
Discussion
The main objective of our study was to survey variation in
gene expression across a diverse set of normal human tissue
t y p e s .  W e  h a v e  r e p o r t e d  h e r e  a  c D N A  m i c r o a r r a y  g e n e -
expression dataset profiling approximately 26,000 human
genes across 115 human tissue specimens representing 35
different tissue types. An unsupervised, two-way hierarchical
clustering of the genes whose expression varied most across
samples showed that at the level of gene expression, the rela-
tionship among tissues was in large part based on their ana-
tomic locations, cellular compositions and physiologic
functions. Tissue-specific features of gene expression were
readily discernable in the hierarchical cluster, as were gene-
expression features related to specific cellular processes (as
inferred from the named genes within these features). Of par-
ticular importance, the function of uncharacterized ESTs
might be deduced by virtue of their inclusion in one of these
clusters. Supervised analysis also identified genes selectively
expressed in each of the tissues types studied, and the analy-
sis of functionally annotated gene sets provided information
on the tissue distribution of specific biological processes, cel-
lular components and molecular functions.
We have also reported here the application of mRNA versus
genomic DNA hybridizations for estimating transcript abun-
dances for expressed genes. Knowledge of transcript abun-
dance should prove useful in prioritizing candidate genes for
use as diagnostic markers or therapeutic targets, for which
more highly expressed genes might be more tenable candi-
dates. It is worth pointing out that our approach for estimat-
ing absolute transcript levels should be applicable to any
cDNA microarray study incorporating a common reference
mRNA.
While many investigators have been using DNA microarrays
to profile gene expression in cancer and other human dis-
eases, scant data exist on profiles of gene expression across
the diversity of normal human tissues. Our cDNA-microar-
ray-based survey of gene expression in normal human tissues
provides a publicly accessible dataset which can be used in
future analyses aimed at better understanding the physiology
of various normal tissues; developing a baseline for compari-
son to diseased tissues, including cancer; identifying tissue-
specific diagnostic markers that signify tissue injury; discov-
ering tissue-specific therapeutic targets (for example, for
treatment of prostate cancer); and identifying tumor-specific
diagnostic markers and therapeutic targets, for which mini-
mal expression in the collection of normal adult human tis-
sues is desirable.
Conclusions
We have used cDNA microarrays to survey gene expression
across a diverse set of normal human tissues. Using unsuper-
vised and supervised analyses, we have identified tissue-spe-
cific patterns of gene expression. Furthermore, by
comparative hybridization to normal genomic DNA, we were
able to estimate transcript abundances and identify the sub-
sets of abundantly expressed tissue-specific genes. Our data-
set provides a baseline for comparison to diseased tissues, as
well as a basis for identifying molecular markers of injury to
specific organs and tissues, and for anticancer therapy.
Materials and methods
Tissue specimens
Normal human tissue specimens were obtained from surgery
(for example, the uninvolved regions of resected tumors) or
from autopsy, with institutional review board approval. Spec-
imens were frozen on dry ice within 30 minutes of surgical
removal or procurement and stored at -80°C. Histological
evaluations were performed by H&E staining of frozen sec-
tions, and a pathologist (J.H. and/or M.vdR.) reviewed all
slides to confirm the anatomical site of origin and histological
normalcy (that is, to rule out inflammation, infection, necro-
sis, malignancy). In total, we selected for study 115 tissue
samples representing 35 different human tissues (Additional
data file 1). Total RNA was isolated from tissues using TRIzol
Reagent (Invitrogen) according to the manufacturer's
instruction, and RNA quality was assessed by the integrity of
rRNA bands following gel electrophoresis. The poly(A)+
m R N A  f r a c t i o n  w a s  t h e n  i s o l a t e d  f r o m  t o t a l  R N A  u s i n g
FastTrack2.0 kit (Invitrogen), and quantified by UV
spectrophotometry.
Expression profiling
Gene-expression profiling was performed essentially as
reported previously [8], and detailed protocols for array fab-
rication and hybridization are available online [28]. Briefly,
Cy5-labeled cDNA was prepared using 2 µg mRNA from nor-
mal tissue samples, and Cy3-labeled cDNA was prepared
using 1.5 µg mRNA common reference, pooled from 11 estab-
lished human cell lines [8]. For each experimental sample,
Cy5- and Cy3-labeled samples were co-hybridized to a cDNA
microarray containing 39,711 human cDNAs, representing
26,260 different genes (UniGene clusters [21]). For the com-
mon reference mRNA (Cy5) versus genomic DNA (Cy3) com-
parisons, normal female genomic DNA was labeled as
described [24]. Following hybridization, microarrays were
imaged using an Axon GenePix 4000 scanner (Axon Instru-
ments). Fluorescence ratios for array elements were extracted
using GenePix software, and uploaded onto the Stanford
Microarray Database (SMD) [29] for subsequent analysis.
The complete microarray dataset is accessible from SMD
[30], or from the Gene Expression Omnibus [31] (accession
number GSE2193).R22.8 Genome Biology 2005,     Volume 6, Issue 3, Article R22       Shyamsundar et al. http://genomebiology.com/2005/6/3/R22
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Data analysis
Fluorescence ratios were normalized by mean-centering
genes for each array (that is, 'global' normalization), and then
by mean centering each gene across all arrays. We included
for analysis only well-measured genes whose expression
varied, as determined by: signal intensity over background
more than twofold in either test or reference channels in at
least 75% of samples; and a fourfold or more ratio variation
from the mean in at least two samples (unless otherwise indi-
cated). Hierarchical clustering was performed and displayed
using Cluster and TreeView software [32]. Tissue-selective
genes were identified using the two-class (each tissue versus
all other tissues) significance analysis of microarrays (SAM)
method [25], which utilizes a modified t-test statistic and
sample-label permutations to evaluate statistical significance.
The false-discovery rate (FDR), an estimate of the fraction of
falsely called tissue-selective genes, varied by tissue, but in all
cases was less than 5% (specific FDRs are listed in Additional
data file 3). For tissue-selective genes, only tissue types with
two or more samples were considered for analysis, and we
only considered genes that were well-measured in more than
50% of the samples for the selected tissue type analyzed. GO
annotations were assigned to arrayed genes using the AmiGO
browser [33] to select relevant GO annotations, and the
'loc2go' file [34] to identify the corresponding sets of genes.
Transcript abundance was estimated by multiplying (for each
gene) the ratio of tissue sample mRNA versus common refer-
ence mRNA by the ratio (average ratio from triplicate experi-
ments) of common reference mRNA versus normal female
genomic DNA. Highly-abundant tissue specific transcripts
were defined for each tissue type as the top (capped at 50
genes) tissue specific transcripts, identified using the SAM
method, from the 1,000 most abundantly expressed tran-
scripts in the full dataset.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a table listing the
normal tissue specimens included in microarray analysis.
Additional data file 2 is a table listing the variably expressed
genes. Additional data file 3 is a table listing tissue-specific
transcripts. Additional data file 4 is a table listing functionally
annotated gene sets. Additional data file 5 is a table listing
highly abundant tissue-specific transcripts. Additional data
file 6 is a figure showing tissue-specific gene expression.
Additional data file 7 is a figure showing expression of func-
tionally annotated gene sets. Additional data file 8 is a figure
showing highly abundant tissue-specific gene expression.
Additional File 1 A table listing the normal tissue specimens included in microarray  analysis Click here for file Additional File 2 A table listing the variably expressed genes. Sheet 1: Dataset rep- resented in Fig. 1, which includes well-measured genes in ≥ 75% of  samples, and with ≥ 4-fold ratio variation from the mean in at least  2 samples; samples ordered by clustering.Sheet 2: Variably  expressed genes which are well-measured in ≥ 75% of samples, with  ≥ 2-fold ratio variation from the mean in at least 2 samples; sam- ples ordered by anatomic site. Sheet 3: Variably expressed genes  which are well-measured in ≥ 25% of samples, with ≥ 4-fold ratio  variation from the mean in at least 2 samples; samples ordered by  anatomic site. Sheet 4: Same dataset as sheet 1, but here ratios  represent relative transcript abundance (See Materials and meth- ods). Sheet 5: Same dataset as sheet 2, but here ratios represent  relative transcript abundance (See Materials and methods). Sheet  6: Same dataset as sheet 3, but here ratios represent relative tran- script abundance (See Materials and methods). Click here for file Additional File 3 A table listing tissue-specific transcripts. Click here for file Additional File 4 A table listing functionally annotated gene sets. Click here for file Additional File 5 A table listing highly abundant tissue-specific transcripts. Click here for file Additional File 6 A figure showing tissue-specific gene expression. Variably- expressed genes determined to be expressed in a tissue-selective  fashion using the SAM method are depicted as described in the leg- end to manuscript Figure 2. a, brain; b, salivary gland; c, esopha- gus; d, stomach; e, small bowel; f, colon; g, pancreas; h, liver; i,  heart; j, skeletal muscle; k, lung; l, kidney; m, bladder;n, prostate;  o, seminal vesicle; p, testis; q, ovary; r, fallopian tube; s, uterus; t,  cervix, u, thyroid; v, parathyroid; w, adrenal; x, lymph node; y,  tonsil; z, thymus; aa, spleen; bb, buffy coat. Click here for file Additional File 7 A figure showing expression of functionally annotated gene sets.  Hierarchical cluster of 115 normal tissue specimens and annotated  gene sets representing examples of specific molecular functions,  cellular components, or biological processes. a, tyrosine kinase  (activity); b, kinase (activity); c, G-protein coupled receptor (activ- ity); d, transcription factor activity; e, ion channel (activity); f,  extracellular matrix (component), g, cell adhesion (process); h,  programmed cell death (process). Click here for file Additional File 8 A figure showing highly abundant tissue-specific gene expression.  Highly-abundant tissue specific transcripts were defined for each  tissue type as the top (capped at 50 genes) tissue specific tran- scripts, identified using the SAM method, from the 1000 most  abundantly expressed transcripts in the full dataset. a, brain; b,  salivary gland; c, esophagus; d, stomach; e, small bowel; f, colon;  g, pancreas; h, liver; i, heart; j, skeletal muscle; k, lung; l, kidney;  m, bladder;n, prostate; o, seminal vesicle; p, testis; q, ovary; r, fal- lopian tube; s, uterus; t, cervix, u, thyroid; v, parathyroid; w, adre- nal; x, lymph node; y, tonsil; z, thymus; aa, spleen; bb, buffy coat. Click here for file
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